Advanced search×

Preclinical investigation of fluorometholone acetate as a potential new adjuvant during vitreous surgery.

Yasuaki Y Hata, Hiroshi H Enaida, Yukio Y Sassa, Akifumi A Ueno, Muneki M Miura, Toshio T Hisatomi, Yoshinobu Y Goto, and Tatsuro T Ishibashi

Graefes Arch Clin Exp Ophthalmol 245(7):1019-25 (2007) PMID 17186258

To examine the effects of intravitreal fluorometholone acetate (FMT) on the morphology and function of the retina and to investigate its possible use for vitreous surgery.

Version: za2963e q8zaa q8zb6 q8zc0 q8zd0 q8ze5 q8zfc q8zgd
Buy PDF

Similar articles you may find interesting…

  1. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
    Takeru Yoshimura, Koh-Hei Sonoda, ... Tatsuro Ishibashi

    PLoS One 4(12):e8158 (2009) PMID 19997642

    View PDF
  2. Trityl dyes patent blue V and brilliant blue G - clinical relevance and in vitro analysis of the function of the outer blood-retinal barrier...
    Stefan S Mennel, Carsten H CH Meyer, ... Gabriele G Thumann

    Dev Ophthalmol (2008) PMID 18535384

    We specifically searched for relevant information regarding the laboratory as well as clinical use of PB and BBG. To evaluate the effect of PB and BBG on the RPE, PB and BBG have been added to an in vitro model of the outer blood-retinal barrier to assess dye-associated barrier properties. Two conce...
    Buy PDF
  3. Brilliant blue in vitreoretinal surgery.
    Hiroshi H Enaida and Tatsuro T Ishibashi

    Dev Ophthalmol (2008) PMID 18535385

    This paper reviews the preclinical effects of brilliant blue G (BBG) on the morphology and functions of the retina, and reports on a pilot study of BBG staining and subsequent peeling of the internal limiting membrane (ILM) during vitreoretinal surgery. BBG solution was injected into rat eyes and in...
    Buy PDF